Loading provider…
Loading provider…
Hematology & Oncology Physician in Los Angeles, CA
NPI: 1427190115Primary Employer
UCLA Medical Plaza
uclahealth.org
HQ Phone
Get MD Gottfried's Phone Numberphone_androidMobile
Get MD Gottfried's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2013 - 2026
CA State Medical License
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Fellowship • Gynecologic Oncology
2005 - 2007
Ludwig Maximilian University of Munich Faculty of Medicine
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 105 | 418 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 80 | 230 |
| 3 | J7050Infusion, normal saline solution , 250 cc | 70 | 334 |
| 4 | 96413Infusion of chemotherapy into a vein up to 1 hour | 66 | 220 |
| 5 | 96367Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 36 | 115 |
Authors: Lorna Rodriguez, Beth Karlan, Wei Zheng, Rebecca Sutphen, Robert A Edwards, Karen Lu
Journal: Nat Commun
Sequencing efforts help to refine the molecular classification of breast cancer.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Curr Opin Obstet Gynecol
Authors: von Minckwitz, Gunter, Untch, Michael, Blohmer, Jens-Uwe, Costa, Serban D, Eidtmann, Holger, Fasching, Peter A, Gerber, Bernd, Eiermann, Wolfgang, Hilfrich, Jörn, Huober, Jens, Jackisch, Christian, Kaufmann, Manfred, Konecny, Gottfried E, Denkert, Carsten, Nekljudova, Valentina, Mehta, Keyur, Loibl, Sibylle
Journal: J Clin Oncol
Publication Date: 2012-04-16
Lead Sponsor: Tesaro, Inc.
Intervention / Treatment: DRUG: Carboplatin, BIOLOGICAL: Bevacizumab, DRUG: Niraparib, DRUG: Paclitaxel, BIOLOGICAL: TSR-042
Lead Sponsor: Sutro Biopharma, Inc.
Intervention / Treatment: DRUG: STRO-002
Lead Sponsor: AbbVie
Collaborators: Gynecologic Oncology Group, European Network of Gynaecological Oncological Trial Groups (ENGOT)
Intervention / Treatment: DRUG: Paclitaxel, DRUG: Topotecan, DRUG: Mirvetuximab Soravtansine, DRUG: Pegylated liposomal doxorubicin